1. Home
  2. >Health Systems
  3. >Our Science
Skip to main content

The future of genomics programs is already here.

High-quality sequencing is table stakes. What sets Helix apart is what happens after; Sequence Once, Query Often®, population-level real-world evidence powered by millions of samples, and continuous evidence and interpretation with Helix Wayfinder™.

Exome+® Assay

Comprehensive exome with enhanced clinical regions.

CAP / CLIA certified

>99% sensitivity, 100% concordance across variant classes.

Multi-Modal Capability

Short-read and long-read whole genome sequencing.

Here’s where we pull ahead

Sequence Once, Query Often®

One sample becomes a lifetime of queryable data — no re-collection, no re-sequencing. Order new panels instantly on existing data.

Population-scale RWE

The Helix Research Network® resolves 45% of VUS that remain uncertain elsewhere — 96% confirmed benign, 9% increase in pathogenic calls.

Read the research

AI-powered interpretation

Wayfinder™ deploys 20+ specialized AI agents in parallel to classify variants against global clinical evidence using ACMG/AMP guidelines.

The intelligence

20+ AI agents. Working in parallel. Reasoning at scale.

Wayfinder™ is Helix's proprietary interpretation engine — a swarm of specialized AI agents that interrogate every variant against global clinical evidence, then synthesize findings using ACMG/AMP guidelines.

  • Parallel agent architecture

    Gene validity, population data, in-silico predictions, phenotype matching, literature mining, functional evidence — simultaneously.

  • Continuous evidence monitoring

    Continual surveillance of PubMed, ClinVar, gnomAD for new evidence.

  • Explainable reasoning

    Every classification shows its complete evidence chain for transparency.

  • Expert validation

    Final review by board-certified geneticists ensures clinical-grade accuracy.

The Helix Research Network

Population-scale evidence. Powering every interpretation.

The Helix Research Network is one of the largest clinicogenomic databases in existence — comprising an expansive community of patients with linked genomic and EHR data.

  • Clinicogenomic scale

    Vast cohorts with exome data + longitudinal EHR.

  • Real-world evidence

    How variants actually manifest in real patients.

  • Population diversity

    Representative of real-world clinical populations.

  • Continuous enrichment

    Every test strengthens the network.

See the science in action

Schedule a walkthrough with our clinical team to learn how Helix's platform can transform your genomics practice.